期刊文献+

可生物降解高分子超细纤维PLA药物缓释体作用于脑胶质瘤的体外研究 被引量:1

In vitro study of controlled biodegradable high molecular superfine fiber PLA release system for glioma
下载PDF
导出
摘要 目的比较可生物降解药物缓释体与单纯抗瘤药物体外抗胶质瘤细胞的作用。方法通过MTT法筛选药物敏感浓度后,应用化学电纺锤工艺将聚乳酸(PLA)与卡氮芥、阿霉素、紫杉醇制成缓释体,并应用高效液相色谱仪测定其缓释率,筛选缓释效果好的缓释体。体外利用L929细胞在空载体浸出液培养后测定吸光度值(OD值),计算相对增殖率(RGR),按六级评分标准评价空载体毒性,0~1级无毒性;利用C6胶质瘤细胞在药物缓释体中培养后计算细胞抑制率(IR)验证药物缓释体的缓释杀瘤效果。结果卡氮芥-PLA缓释体、阿霉素-PLA缓释体缓释平稳,紫杉醇-PLA缓释体缓释效果差并有暴释。空载体毒性为0~1级。卡氮芥-PLA缓释体平稳释放后细胞抑制率为12.3%。结论载体材料无毒性作用,卡氮芥-PLA缓释体缓释效果好,体外杀瘤平稳、持续杀瘤,可进一步通过体内动物实验验证其有效性。 Objective To compare in vitro antitumor effects of controlled biodegradable drug release system and simplex anti-tumor drug in the patients with glioma Methods After selecting optimal dose of drug by MTT method, polylactide (PLA) was mixed with BCNU, adriamycin and taxol, respectively, to make them into controlled release systems by chemical and electric spindle technics, and their controlled release rates were measured by high-performance liquid chromatography (HPLC), from which the best system was selected based on the release rate, After L929 cells were cultured in empty vector lixivium in vitro, OD value was measured, relative growth rate (RGR) calculated, and toxicity of the empty vector evaluated according to 6-grade scoring criteria, Grades 0-1 are avirulent, Cell inhibition rate (IR) was calculated after C6 glioma cells were cultured in the controlled drug release system for testifying tumor-killing effect of the controlled drug release system. Results Efficacy of controlled release of BCNU-PLA and adriamycin-PLA release systems is steady, but that of taxol-PLA controlled release system is not steady with a sudden release. Empty vector toxicity was at grades 0-1. Inhibition rate of cell growth by controlled BCNU-PLA release system was 12.3%. Conclusion Vector material is not toxic. The controlled BCNU-PLA release system can kill glioma cells in vitro effectively and consistently, and the efficacy can be validated through further animal experiments.
出处 《中国微侵袭神经外科杂志》 CAS 2006年第12期558-561,共4页 Chinese Journal of Minimally Invasive Neurosurgery
关键词 神经胶质瘤 生物降解 迟效制剂 卡莫司汀 聚乳酸 glioma biodegradation delayed-action preparations carmustine polylactide
  • 相关文献

参考文献9

  • 1Wallner KE,Galicich JH,Krol G,et al.Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma[J].Int J Radiat Oncol Biol Phys,1989; 16(6):1405-1409.
  • 2Langer R,Folkman J.Polymers for the sustained release of proteins and other macromolecules[J].Nature,1976; 263(5580):797-800.
  • 3Saltzman WM.Antibodies for treating and preventing diseases:the potential role of polymeric controlled release[J].Crit Rev Ther Drug Carrier Syst,1993; 10(2):111-142.
  • 4Murray JB,Brown L,Langer R,et al.A micro sustained release system for epidermal growth factor[J].In Vitro,1983;19(10):743-748.
  • 5Walter KA,Cahan MA,Gur A,et al.Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma[J].Cancer Res,1994; 54(8):2207-2212.
  • 6张又平,徐新女,王金环,鲁格,刘萍,苏同芳,刘宏胜,祁建滨,高波.脑胶质瘤缓释化疗剂^3H-BCNU聚乳酸的体内外释药研究[J].中国危重病急救医学,2003,15(9):568-569. 被引量:6
  • 7于振国,桂松柏,娄飞云.多聚体缓释化疗治疗脑胶质瘤[J].中华神经外科杂志,2003,19(3):178-180. 被引量:10
  • 8Brem H,Mahaley MS Jr,Vick NA,et al.Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas[J].J Neurosurg,1991; 74(3):441-446.
  • 9Isaka T,Maruno M,Nakata H,et al.Effectiveness of spray application of ACNU in the local control of malignant gliomas:report of two cases[J].Neurol Res,2000; 22(2):181-184.

二级参考文献5

  • 1Pech I V, Peterson K, Cairncross J G.Chemotherapy of brain tumors[J].Oncology, 1998,12 (4) : 537 - 543.
  • 2Tamargo R L, Myseros J S, Brem H.Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain[J]. Cancer Res, 1993,53(2):329 - 333.
  • 3Sipos E P, Tyler B, Piantadosi S, et al.Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors [J]. Cancer Chemother Pharmacol, 1997,39 (5) ; 383 -389.
  • 4Fung L K, Shin M, Tyler B, et al. Chemotherapeutic drugs released from polymers : distribution of 1,3 - bis (2 - chloroethyl )- 1 - nitrosourea in the rat brain [J]. Pharm Res, 1996,13 (5) : 671 - 672.
  • 5Langer R. Biomaterials in drug delivery and tissue engineering., one laboratory's experience [J]. Acc Chem Res, 2000, 33 (2):94-96.

共引文献14

同被引文献23

  • 1高昊,平其能,顾月清.生物可降解载药纤维的制备、特征表征及释药特性的研究[J].生物医学工程学杂志,2008,25(4):870-873. 被引量:1
  • 2刘娟,肖丽英,李伟,丁一,张萍,袁明龙.可吸收聚乳酸-替硝唑抗菌缓释剂体外药物释放效果的测定[J].华西口腔医学杂志,2005,23(3):237-239. 被引量:3
  • 3Al en TM,Cul is PR. Drug delivery systems:entering the mainstream[J].{H}SCIENCE,2004,(5665):1818-1822.
  • 4Deitzel JM,Kleinmeyer JD,Hirvonen JK. Control ed deposition of electrospun poly(ethylene oxide)fibers[J].{H}POLYMER,2000.8163-8170.
  • 5Auras R,Harte B,Selke S. An overview of polylactides as packaging materials[J].{H}Macromolecular Bioscience,2004,(09):835-864.doi:10.1002/mabi.200400043.
  • 6Drumright RE,Gruber PR,Henton DE. Polylactic acid technology[J].{H}Advanced Materials,2000.1841-1846.
  • 7Pelouze J. Memoire sure l'acide lactique[J].Annual Chimie,1845,(13):257-268.
  • 8Carothers WH,Dorough GL,Van Natta FJ. Studies of polymerization and ring formation.X.The reversible polymerization of six-membered cyclic ester[J].{H}Journal of the American Chemical Society,1932.761-772.
  • 9Lowe CE. Preparation of high molecular weight polyhydroxyacetic ester[M].US Patent,2668162,1954.
  • 10Yol es S,Leaffe T,Ward L. Control ed release of biological y active drugs[J].Bul Parenter Drug Assoc,1976,(06):306-312.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部